Heterogeneous Response to Immunotherapy in a Patient with Tonsillar Squamous Cell Carcinoma Assessed by <sup>18</sup>F-FDG PET/CT

Heterogeneous Response to Immunotherapy in a Patient with Tonsillar Squamous Cell Carcinoma Assessed by <sup>18</sup>F-FDG PET/CT

Tonsillar carcinoma is the second most common malignancy of the head and neck region, with Squamous Cell Carcinoma (TSCC) as the most common histological type (>90%). For the advanced stage of TSCC, radiotherapy with or without platinum-based chemotherapy is the only therapeutic option. Immuno-ch...

Full description

Bibliographic Details
Main Authors: Artor Niccoli Asabella, Anna Giulia Nappi, Orsola Trani, Angela Sardaro, Giuseppe Rubini
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Diagnostics
Subjects:
tonsillar squamous cell carcinoma
immunotherapy
<sup>18</sup>F-FDG PET/CT
multimodality imaging
Online Access:https://www.mdpi.com/2075-4418/11/2/348

Internet

https://www.mdpi.com/2075-4418/11/2/348

Similar Items